Stay up-to-date with the Sun Pharma Stock Liveblog, your trusted source for real-time updates and thorough analysis of a ...

Sun Pharma expects to close the acquisition on or before 31 July 2026.

Stock of Sun Pharmaceutical is in focus as the company’s shares are set to turn ex- dividend tomorrow with its final dividend ...

Stay informed with the Sun Pharma Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of ...

Sun Pharmaceutical Industries has lined up 11 banks, including State Bank of India (SBI), to finance its $11.75 billion ...

The brokerage expects domestic-focused pharma companies to outperform peers exposed to high-value US generic opportunities, ...

The size of SBI’s funding underscores the growing appetite among state-run banks to back acquisitions by Indian companies, which have increasingly pursued overseas targets to gain access to new ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Sun Pharma shares rose 0.65 per cent to close at Rs 1,798.80. At this level, the stock has climbed 4.56 per cent year-to-date (YTD).

Get Sun Pharmaceutical Industries latest Profit & Loss account, Income Statement, Financial Statements and Sun Pharmaceutical Industries detailed profit and loss accounts including income, expenses, ...

While many campaigns for plaque psoriasis treatments focus on erasing the external effects of the condition, Sun Pharma’s latest Ilumya push is emphasizing the importance of looking inward, too. The ...

Sun Pharmaceutical Industries described the acquisition as a strategic investment to strengthen its product portfolio.